The European Medicines Agency reviews submissions for pharmaceutical products.
2 reports, 2 independent
Updated Jul 30
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The European Medicines Agency reviews submissions for pharmaceutical products.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
-
GSK
British multinational pharmaceutical and biotechnology company
Related events
- The FDA and European Medicines Agency are harmonizing regulatory review of drug applications.
- GSK gained FDA clearance for a lung cancer medicine, while the FDA began reviewing other highly anticipated drugs.
- AbbVie submitted an application for risankizumab approval to the European Medicines Agency.
- Both the FDA and the European Medicines Agency govern drug approval processes.
- GSK and Novartis are identified as major pharmaceutical companies.